A detailed history of Rogco, LP transactions in Amgen Inc stock. As of the latest transaction made, Rogco, LP holds 994 shares of AMGN stock, worth $319,978. This represents 0.13% of its overall portfolio holdings.

Number of Shares
994
Previous 994 -0.0%
Holding current value
$319,978
Previous $311 Million 3.12%
% of portfolio
0.13%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $34,945 - $42,468
-133 Reduced 11.8%
994 $311 Million
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $2,688 - $3,245
-10 Reduced 0.88%
1,127 $320 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $1,278 - $1,442
5 Added 0.44%
1,137 $327 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $247,511 - $307,292
1,132 New
1,132 $304 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rogco, LP Portfolio

Follow Rogco, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.